GGrantIndex
← Search

CLINICAL TRIAL: A PHASE II RANDOMIZED, CROSS-OVER STUDY TO COMPARE THE STEADY ST

$66,517M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
CLINICAL TRIAL: A PHASE II RANDOMIZED, CROSS-OVER STUDY TO COMPARE THE STEADY ST · GrantIndex